JP Morgan Chase
BOLD

JP Morgan Chase’s Boundless Bio BOLD Stock Holding History

JP Morgan Chase’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$439 Buy
179
+10
+6% +$15 ﹤0.01% 7437
2026
Q1 		$183 Hold
169
– – ﹤0.01% 7262
2025
Q4 		$203 Buy
+169
New +$211 ﹤0.01% 7156
2025
Q3 		– Sell
-1,127
Closed -$1.14K – 7777
2025
Q2 		$1.14K Sell
1,127
-18,125
-94% -$24.1K ﹤0.01% 6609
2025
Q1 		$29.1K Sell
19,252
-59,643
-76% -$124K ﹤0.01% 6039
2024
Q4 		$229K Buy
78,895
+68,959
+694% +$201K ﹤0.01% 5421
2024
Q3 		$34.5K Buy
9,936
+7,247
+270% +$26.3K ﹤0.01% 6102
2024
Q2 		$10.4K Buy
+2,689
New +$25.7K ﹤0.01% 6256

Other funds holding BOLD

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

JP Morgan Chase's BOLD Position: Q2 2026 in Review

JP Morgan Chase increased its Boundless Bio (BOLD) stake by 5.9% in Q2 2026, buying an estimated $15 and bringing the position to 179 shares worth $439. The position accounts for ﹤0.01% of the portfolio, ranked #7437.

JP Morgan Chase first reported a position in BOLD in Q2 2024 and has held it in 8 quarters since. The position peaked at $229K in Q4 2024. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • JP Morgan Chase held 179 shares of Boundless Bio worth $439 as of Q2 2026.
  • JP Morgan Chase bought 10 Boundless Bio shares in Q2 2026, an estimated $15.
  • Boundless Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7437 holding.
  • JP Morgan Chase first reported a position in Boundless Bio in Q2 2024 and has held it in 8 quarters since.
  • JP Morgan Chase's Boundless Bio position peaked at $229K in Q4 2024.
  • 40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.